DK166905B1 - Middel, der kan anvendes til passiv heterolog immunisering af et pattedyr - Google Patents

Middel, der kan anvendes til passiv heterolog immunisering af et pattedyr Download PDF

Info

Publication number
DK166905B1
DK166905B1 DK053485A DK53485A DK166905B1 DK 166905 B1 DK166905 B1 DK 166905B1 DK 053485 A DK053485 A DK 053485A DK 53485 A DK53485 A DK 53485A DK 166905 B1 DK166905 B1 DK 166905B1
Authority
DK
Denmark
Prior art keywords
antibody
antigen
bird
antibodies
mammal
Prior art date
Application number
DK053485A
Other languages
Danish (da)
English (en)
Other versions
DK53485D0 (da
DK53485A (da
Inventor
Ralph J Stolle
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of DK53485D0 publication Critical patent/DK53485D0/da
Publication of DK53485A publication Critical patent/DK53485A/da
Application granted granted Critical
Publication of DK166905B1 publication Critical patent/DK166905B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK053485A 1984-02-07 1985-02-06 Middel, der kan anvendes til passiv heterolog immunisering af et pattedyr DK166905B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57780484A 1984-02-07 1984-02-07
US57780484 1984-02-07
US06/622,130 US4748018A (en) 1984-02-07 1984-06-19 Method of passive immunization of mammals using avian antibody
US62213084 1984-06-19

Publications (3)

Publication Number Publication Date
DK53485D0 DK53485D0 (da) 1985-02-06
DK53485A DK53485A (da) 1985-08-08
DK166905B1 true DK166905B1 (da) 1993-08-02

Family

ID=27077340

Family Applications (2)

Application Number Title Priority Date Filing Date
DK053485A DK166905B1 (da) 1984-02-07 1985-02-06 Middel, der kan anvendes til passiv heterolog immunisering af et pattedyr
DK227190A DK227190A (da) 1984-02-07 1990-09-20 Fremgangsmaade til passiv immunisering af pattedyr under anvendelse af bovid-antistof og midler hertil

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK227190A DK227190A (da) 1984-02-07 1990-09-20 Fremgangsmaade til passiv immunisering af pattedyr under anvendelse af bovid-antistof og midler hertil

Country Status (12)

Country Link
US (1) US4748018A (xx)
EP (2) EP0152270B1 (xx)
JP (6) JP2548115B2 (xx)
AT (1) ATE135016T1 (xx)
CA (3) CA1275044A (xx)
DE (1) DE3504221C2 (xx)
DK (2) DK166905B1 (xx)
GR (1) GR850323B (xx)
HK (1) HK1000183A1 (xx)
IE (1) IE64365B1 (xx)
IL (1) IL74155A (xx)
NZ (1) NZ211030A (xx)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
US5853765A (en) * 1982-06-03 1998-12-29 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
ES2052496T3 (es) * 1985-11-25 1994-07-16 Ghen Corp Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso.
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
US5565550A (en) * 1987-05-04 1996-10-15 Dana Farber Cancer Institute Antibodies to ICAM-2, and fragments thereof
JP2641228B2 (ja) * 1988-01-22 1997-08-13 鐘紡株式会社 抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
US5059419A (en) * 1988-06-09 1991-10-22 Grand Laboratories, Inc. Streptococcus suis antiserum and its use in treating Streptococcus suis infections
JP2689511B2 (ja) * 1988-08-18 1997-12-10 ライオン株式会社 食 品
US6511664B1 (en) 1989-03-09 2003-01-28 Dana Farber Cancer Institute Intercellular adhesion molecule—2 and its binding ligands
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
US6932968B1 (en) 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
US7005560B1 (en) * 1989-10-27 2006-02-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms
US5958413A (en) * 1990-11-01 1999-09-28 Celltech Limited Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
JP2553445B2 (ja) * 1992-12-17 1996-11-13 同仁医薬化工株式会社 抗体の安定化方法
NZ254326A (en) * 1993-05-26 1998-01-26 Dcv Inc Substituted Under Sect An anti-cholesterol egg, its production and use
US6068862A (en) * 1993-06-30 2000-05-30 Taiyo Kagaku Co., Ltd. Tea-derived feed additive and animal feed containing the same
CA2179383A1 (en) * 1994-01-14 1995-07-20 Ira D. Goldfine Antagonists to insulin receptor tyrosine kinase inhibitor
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
CA2182976C (en) * 1994-02-09 2011-07-12 Daryll A. Emery Active immunization using a siderophore receptor protein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
ATE238810T1 (de) * 1994-08-05 2003-05-15 Wisconsin Alumni Res Found Cck-antikörper zur verbesserung der futterverwertung
US5814316A (en) * 1994-08-05 1998-09-29 Wisconsin Alumni Research Foundation Compound to mimick a naturally occurring peptide's effect
US5939269A (en) * 1994-12-28 1999-08-17 The Regents Of The University Of California Antagonists to insulin receptor tyrosine kinase inhibitor
WO1996030043A1 (en) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals Treatment for verotoxin-producing escherichia coli
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
WO1997033915A1 (de) * 1996-03-12 1997-09-18 Ovoimmun Gmbh Aviäre, vitelline, gegen hiv-antigene gerichtete antikörper
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
CA2267421A1 (en) * 1996-10-02 1998-04-09 Marilyn A. Coleman Oral administration of chicken yolk antibodies to treat disease
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JPH10298105A (ja) * 1997-04-23 1998-11-10 Gen Corp:Kk 腸管出血性大腸菌による感染症の予防剤および治療剤
AU7712598A (en) * 1997-06-04 1998-12-21 Regents of The University of Arizona, The Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
US6086878A (en) * 1997-08-21 2000-07-11 Dcv, Inc. Method of increasing muscle protein and reducing fat in animals
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6395273B1 (en) * 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
JP2000351735A (ja) 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
US7241443B1 (en) * 1999-07-15 2007-07-10 Camas Incorporated Immunogen adherence inhibitor and method of making and using same
US7238351B2 (en) * 1999-07-15 2007-07-03 Peter Nash Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
WO2001013928A1 (fr) * 1999-08-24 2001-03-01 Ortho Corporation Co., Ltd. Procedes de pasteurisation d'une substance immune contenant un facteur anti-inflammatoire et son utilisation
US6706267B1 (en) 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
WO2001072141A2 (en) * 2000-03-24 2001-10-04 Trouw Nutrition Usa Combination of plasma and hyperimmunized products for increased performance of weanlings
ATE322288T1 (de) * 2001-01-03 2006-04-15 Epitopix Llc Zusammensetzungen zur immunisierung sowie deren verwendung
CA2339436A1 (fr) 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
AU2002318137A1 (en) * 2001-05-18 2002-12-03 Arkion Life Sciences Method of increasing uniformity in avians
US20030003104A1 (en) * 2001-07-02 2003-01-02 John Mottola Method for removal of pathogens from a localized environment
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
BR0117062A (pt) * 2001-12-28 2005-12-13 Camas Inc Métodos para promover o desenvolvimento de animais comestìveis, para substancialmente reduzir ou eliminar a incidência de doenças e para produzir um inibidor de aderência microbiana, e, inibidor da aderência microbiana
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
MXPA04007694A (es) * 2002-02-11 2004-11-10 Arkion Life Sciences Llc Factor inhibidor de citosina purificada.
US20040005327A1 (en) * 2002-05-16 2004-01-08 Subramanian Iyer Immune T-cell stimulation
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
ES2371395T3 (es) * 2003-02-19 2011-12-30 Camas Incorporated Inhibidor de adherencia de inmunógenos y procedimiento de preparación y uso del mismo.
US9701737B2 (en) * 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
WO2005003173A1 (en) * 2003-07-07 2005-01-13 Luiz Fernando Mesquita Process of obtaining a freeze-dried complex from mammal gland secretion
WO2005028665A2 (en) * 2003-09-19 2005-03-31 Epitopix, Llc Campylobacter polypeptides and methods of use
ATE497782T1 (de) * 2004-04-16 2011-02-15 Univ Alberta Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie
US8877187B2 (en) * 2005-07-25 2014-11-04 Avianax, Llc Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
AU2006285306B2 (en) * 2005-07-25 2012-07-19 Avianax, Llc. Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US20070264264A1 (en) * 2005-08-30 2007-11-15 La Belle Associates, Inc. Method and composition for conferring immunity in mammals
CA2521156A1 (en) * 2005-09-16 2007-03-16 John Hare Antibodies as growth promoting agents
EP1790358A1 (en) * 2005-11-23 2007-05-30 Université de Reims Champagne-Ardennes Protein constructs designed for targeting and lysis of cells
EP2368569A3 (en) 2006-01-18 2012-05-02 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
JP4753808B2 (ja) * 2006-06-20 2011-08-24 アサマ化成株式会社 感染症予防食品添加用組成物
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US8282928B2 (en) * 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
SI2162133T1 (sl) 2007-07-09 2016-11-30 Nestec S.A. Postopki za zmanjšanje alergij, ki jih povzročajo alergeni iz okolja
CN101951948B (zh) 2007-08-31 2015-12-09 芝加哥大学 与针对葡萄球菌性肺部疾病和病症进行免疫相关的方法和组合物
US20110166328A1 (en) * 2008-09-02 2011-07-07 Huan Nguyen Avian Antibodies Specific to Influenza Virus and Technologically Simple Methods of Their Manufacture and Use
BRPI0920041A2 (pt) 2008-10-06 2017-06-27 Univ Chicago composições e processos relacionados às proteínas eap, emp e/ou adsa bacterianas
EP3281947B1 (en) 2009-04-03 2020-02-12 The University of Chicago Compositions and methods related to protein a (spa) variants
SG175142A1 (en) 2009-04-27 2011-12-29 Immuron Ltd Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
US10266585B2 (en) 2009-08-28 2019-04-23 The Board Of Regents Of The Univerity Of Texas System Methods of treating brain injury
US8808699B2 (en) 2010-04-05 2014-08-19 The University Of Chicago Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
CN102933232A (zh) * 2010-05-07 2013-02-13 卡马斯股份有限公司 免疫原粘附及其制备和使用方法
SG186290A1 (en) 2010-07-02 2013-01-30 Univ Chicago Compositions and methods related to protein a (spa) variants
ES2628032T3 (es) 2010-08-17 2017-08-01 Immuron Limited Preparación de inmunoglobulina enriquecida con anti-LPS para su uso en el tratamiento y/o la profilaxis de un trastorno patológico
EP2614074A1 (en) 2010-09-09 2013-07-17 The University of Chicago Methods and compositions involving protective staphylococcal antigens
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
MX340019B (es) * 2010-11-23 2016-06-22 Pantheryx Inc Composiciones y metodos para el tratamiento en aplicaciones clinicas de amplio espectro, no diferenciadas o combinadas.
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
EP2744517B1 (en) 2011-08-15 2019-03-13 The University of Chicago Compositions and methods related to antibodies to staphylococcal protein a
CN104703622B (zh) 2012-04-26 2017-05-24 芝加哥大学 与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
US9968668B2 (en) 2012-04-26 2018-05-15 The University Of Chicago Staphylococcal coagulase antigens and methods of their use
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
US10144775B2 (en) 2013-04-19 2018-12-04 Immuron Limited Methods and compositions for the treatment and/or prophylaxis of Clostridium difficile associated disease
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
WO2017173398A1 (en) 2016-04-01 2017-10-05 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
US11413336B2 (en) 2018-03-23 2022-08-16 Board Of Regents, The University Of Texas System Coccidioides antigens and methods of their use
US11339387B2 (en) 2018-05-22 2022-05-24 The Government Of The United States Of America As Represented By The Secretary Of Homeland Security Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
US11701423B2 (en) 2021-03-12 2023-07-18 Lay Sciences, Inc. Hyperimmunized egg product for treatment or prevention of coronavirus infection
CN117320751A (zh) 2021-05-17 2023-12-29 雀巢产品有限公司 包含抗-fel-d1分子和动物消化物的猫食物补充剂
WO2023212604A1 (en) 2022-04-27 2023-11-02 Lay Sciences, Inc. Targeted anti-sglt1 avian igy antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes
WO2023220243A1 (en) 2022-05-13 2023-11-16 Prodigy Biotech, Inc. Formulations for oral delivery of polypeptides, antibodies and proteins and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
US3646193A (en) * 1969-07-25 1972-02-29 Joseph B Michaelson Iga antibody from lacteal fluids
CH590064A5 (xx) * 1973-11-28 1977-07-29 Biokema Sa
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
GB2057451B (en) * 1979-09-05 1983-05-05 South African Inventions Immunological preparations comprising egg yolk antibodies
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit

Also Published As

Publication number Publication date
IE850289L (en) 1985-08-07
NZ211030A (en) 1989-11-28
IL74155A (en) 1989-06-30
EP0395120B1 (en) 1996-03-06
DK227190D0 (da) 1990-09-20
JPH08231427A (ja) 1996-09-10
AU3829685A (en) 1985-08-15
EP0395120A3 (en) 1990-12-19
DK227190A (da) 1990-09-20
EP0152270A3 (en) 1988-01-27
JP2543633B2 (ja) 1996-10-16
CA1276884C (en) 1990-11-27
JP2698779B2 (ja) 1998-01-19
JPH04352729A (ja) 1992-12-07
IE64365B1 (en) 1995-07-26
AU583808B2 (en) 1989-05-11
ATE135016T1 (de) 1996-03-15
JP2723870B2 (ja) 1998-03-09
HK1000183A1 (en) 1998-01-23
US4748018A (en) 1988-05-31
JPH08231426A (ja) 1996-09-10
GR850323B (xx) 1985-06-06
DK53485D0 (da) 1985-02-06
EP0152270B1 (en) 1992-09-16
EP0395120A2 (en) 1990-10-31
DK53485A (da) 1985-08-08
JP2698778B2 (ja) 1998-01-19
JPH08231424A (ja) 1996-09-10
EP0152270A2 (en) 1985-08-21
CA1275044A (en) 1990-10-09
JPS60248628A (ja) 1985-12-09
DE3504221C2 (de) 1994-05-19
JPH08231425A (ja) 1996-09-10
JP2548115B2 (ja) 1996-10-30
IL74155A0 (en) 1985-04-30
JP2690476B2 (ja) 1997-12-10
DE3504221A1 (de) 1985-12-19
CA1276883C (en) 1990-11-27

Similar Documents

Publication Publication Date Title
DK166905B1 (da) Middel, der kan anvendes til passiv heterolog immunisering af et pattedyr
Tsubokura et al. Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni‐infected chickens
Kovacs-Nolan et al. Avian egg antibodies: basic and potential applications
AU729502B2 (en) Oral administration of chicken yolk antibodies to treat disease
Wiedemann et al. Chicken egg antibodies for prophylaxis and therapy of infectious intestinal diseases: V. in vivo studies on protective effects against Escherichia coli diarrhea in pigs
JPH0657663B2 (ja) 多機能特異的抗体の製造方法
Stokes et al. The immune response of mice to bacterial antigens given by mouth.
JPH07252165A (ja) 免疫モジュレータおよびその製造方法
WO1999002188A1 (en) Hen egg yolk antibodies to clostridium difficile antigens and use in therapy for pseudomembranous colitis
TW210289B (xx)
KR100267746B1 (ko) 돼지 대장균 설사증 예방 및 치료용 난황항체를 이용한 경구용 면역제제
AU1248400A (en) Egg anti-inflammatory composition and method of treating and preventing inflammation
Abou Elazab et al. Induction of immune suppression in the chick by an optimal dose of an immunizing antigen in the presence of its specific maternal antibody
IE75217B1 (en) Method of passive immunization of mammals using bovid antibody and compositions for same
KR20010037612A (ko) 돼지 대장균 설사증 예방 및 치료용 특이항체를 포함한 난황건조분말을 이용한 사료첨가제
WO2004002529A1 (en) Supplemented antibody in circulating system of newborns

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired